Легочные эозинофилии: диагностика, подходы к терапии
https://doi.org/10.18093/0869-0189-2012-0-4-106-115
Аннотация
Легочные эозинофилии: диагностика, подходы к терапии.
Об авторах
Э. Х. Анаев
ФГУ "НИИ пульмонологии" ФМБА России
Россия
Россия
д. м. н., зав. лабораторией неинвазивных методов диагностики клинического отдела
105077, Москва, ул. 11-я Парковая, 32, корп. 4. Тел.: (495) 465-53-84.
А. Г. Чучалин
ФГУ "НИИ пульмонологии" ФМБА России
Россия
Россия
д. м. н., акад. РАМН, проф., директор
105077, Москва, ул. 11-я Парковая, 32, корп. 4. Тел.: (495) 465-52-64.
Список литературы
1. Allen J.N., Davis W.B. Eosinophilic lung diseases. Am. J. Respir. Crit. Care Med. 1994; 150: 1423–1438.
2. Campos L.E.M., Pereira L.F.F. Pulmonary eosinophilia. J. Bras. Pneumol. 2009; 35 (6): 561–573.
3. Kroegel C. The role of eosinophils in asthma. Lung 1990; 168 (Suppl.): 5–17.
4. Chusid M.J. Eosinophilia in childhood. Immunol. Allergy Clin. N. Am. 1999; 19 (2): 327–346.
5. Wardlaw A.J., Moqbel R., Kay A.D. Eosinophils: biology and role in disease. Adv. Immunol. 1995; 60: 151–266.
6. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000; 105(4): 651–663.
7. Weller P.F. The immunobiology of eosinophils. N. Engl. J. Med. 1991; 324 (16): 1110–1118.
8. Holgate S.T., Roche W.R., Church M.K. The role of the eosinophil in asthma. Am. Rev. Respir. Dis. 1991; 143 (3, Pt 2): S66–S70.
9. Gorski P., Palczynski C. Eosinophils in bronchial asthma. Allergol. Immunopathol. (Madr.) 1989; 17 (2): 113–116.
10. Weller P.F., Plaut M., Taggart V., Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J. Allergy Clin. Immunol. 2001; 108 (2): 175–183.
11. Rothenberg M.E. Eosinophilia. N. Engl. J. Med. 1998; 338 (22): 1592–1600.
12. Woolley K.L., Adelroth E., Woolley M.J. et al. Granulocytemacrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur. Respir. J. 1994; 7 (9): 1576–1584.
13. Bochner B.S. Systemic activation of basophils and eosinophils: Markers and consequences. J. Allergy Clin. Immunol. 2000; 106 (5): S292–S302.
14. Griffin E., Hakansson L., Formgren H. et al. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J. Allergy Clin. Immunol. 1991; 87: 548–557.
15. Fujitaka M., Nomura S., Sakura N. et al. Morning and afternoon serum levels of cortisone and cortisol in asthmatic patients. Clin. Chim. Acta 2000; 299 (1–2): 101–108.
16. Jeong Y.J., Kim K.I., Seo I.J. et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007; 27 (3): 617–637.
17. Abramson N., Melton B. Leukocytosis: basics of clinical assessment. Am. Fam. Physician 2000; 62 (9): 2053–2060.
18. Bateman E.D., Hurd S.S., Barnes P.J. et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 143–178.
19. Wever A.M., Wever-Hess J., Hensgens H.E., Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. Respir. Med. 1994; 88: 613–621.
20. Imai C., Yamazaki H., Tanaka Y. et al. Ratio of eosinophil cationic protein / eosinophil count as a new marker in children with acute asthma. Pediatr. Int. 1999; 41 (2): 142–146.
21. Bain G.A., Flower C.D. Pulmonary eosinophilia. Eur. J. Radiol. 1996; 23: 3–8.
22. Johkoh T., Muller N.L., Akira M. et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000; 216: 773–780.
23. Fernandez Perez E.R., Olson A.L., Frankel S.K. Eosinophilic lung diseases. Med. Clin. N. Am. 2011; 95 (6): 1163–1187.
24. Allen J. Acute eosinophilic pneumonia. Semin. Respir. Crit. Care Med. 2006; 27 (2): 142–147.
25. Philit F., Etienne-Mastroianni B., Parrot A. et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am. J. Respir. Crit. Care Med. 2002; 166 (9): 1235–1239.
26. Uchiyama H., Suda T., Nakamura Y. et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest 2008; 133 (5): 1174–1180.
27. Wechsler M.E. Pulmonary eosinophilic syndromes. Immunol. Allergy Clin. N. Am. 2007; 27: 477–492.
28. Mochimaru H., Kawamoto M., Fukuda Y., Kudoh S. Clinicopathological differences between acute and chronic eosinophilic pneumonia. Respirology 2005; 10: 76–85.
29. Choi Y.H., Im J.G., Han B.K. et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000; 117: 117–124.
30. Bochner B.S., Gleich G.J. What targeting eosinophils has taught us about their role in diseases. J. Allergy Clin. Immunol. 2010; 126 (1): 16–25.
31. Roufosse F., Weller P.F. Practical approach to the patient with hypereosinophilia. J. Allergy Clin. Immunol. 2010; 126 (1): 39–44.
32. Winn R.E., Kollef M.H., Meyer J.I. Pulmonary involvement in the hypereosinophilic syndrome. Chest 1994; 105: 656–660.
33. Roufosse F.E., Goldman M., Cogan E. Hypereosinophilic syndromes. Orphanet J. Rare Dis. 2007; 2: 37–48.
34. Patterson K., Strek M.E. Allergic bronchopulmonary aspergillosis. Proc. Am. Thorac. Soc. 2010; 7 (3): 237–244.
35. Gibson P.G. Allergic bronchopulmonary aspergillosis. Semin. Respir. Crit. Care Med. 2006; 27 (2): 185–191.
36. Franquet T., Muller N.L., Gimenez A. et al. S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. RadioGraphics 2001; 21: 825–837.
37. Taylor A.J.N. Pulmonary eosinophilia. Medicine 1995; 23 (8): 356–360.
38. Ward S., Heyneman L.E., Flint J.D. et al. Bronchocentric granulomatosis: computed tomographic findings in five patients. Clin. Radiol. 2000; 55: 296–300.
39. Kuzucu A. Parasitic diseases of the respiratory tract. Curr. Opin. Pulm. Med. 2006; 12 (3): 212–221.
40. Chitkara R.K., Krishna G. Parasitic pulmonary eosinophilia. Semin. Respir. Crit. Care Med. 2006; 27 (2): 171–184.
41. Feldman G.J., Parker H.W. Visceral larva migrans associated with the hypereosinophilic syndrome and the onset of severe asthma. Ann. Intern. Med. 1992; 116 (10): 838–840.
42. Savani D.M., Sharma O.P. Eosinophilic lung disease in the tropics. Clin. Chest Med. 2002; 23 (2): 377–396.
43. Ong R.K., Doyle R.L. Tropical pulmonary eosinophilia. Chest 1998; 113(6): 1673–1679.
44. Pneumotox on line. http://www.pneumotox.com
45. Cacoub P., Musette P., Descamps V. et al. The DRESS syndrome: a literature review. Am. J. Med. 2011; 124 (7): 588–597.
46. Criado P.R., Criado R.F., Avancini Jde M., Santi C.G. Drug reaction with eosinophilia and systemic symptoms (DRESS) / Drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An. Bras. Dermatol. 2012; 87 (3): 435–449.
47. Schreiber J. Medikamentos induzierte Lungenerkrankungen. Dtsch. Med. Wschr. 2011; 136 (13): 631–634.
48. Souza C.A., Muller N.L., Johkoh T., Akira M. Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients. Am. J. Roentgenol. 2006; 186 (2): 368–373.
49. Taniguchi M., Tsurikisawa N., Higashi N. et al. Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy. Allergol. Int. 2007; 56 (2): 97–103.
50. Lanham J.G., Elkon K.B., Pusey C.D., Hughes G.R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63 (2): 65–81.
51. Shimbo J., Onodera O., Tanaka K., Tsuji S. Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast. Clin. Rheumatol. 2005; 24: 661–662.
52. Wechsler M.E., Garpestad E., Flier S.R. et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998; 279: 455–457.
53. Brown K.K. Pulmonary vasculitis. Proc. Am. Thorac. Soc. 2006; 3 (1): 48–57.
54. Eustace J.A., Nadasdy T., Choi M. The Churg Strauss syndrome. J. Am. Soc. Nephrol. 1999; 10 (9): 2048–2055.
55. Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol. Int. 2007; 56: 87–96.
56. Di Biagio E., Sanchez-Borges M., Desenne J.J. et al. Eosinophilia in Hodgkin's disease: a role for interleukin 5. Int. Arch. Allergy Immunol. 1996; 110 (3): 244–251.
57. Alonso-Ruiz A., Zea-Mendoza A.C., Salazar-Vallinas J.M. et al. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin. Arthr. Rheum. 1986; 15 (3): 200–212.
58. Solomon J., Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin. Respir. Crit. Care Med. 2006; 27 (2): 192–197.
59. Allen J.A., Peterson A., Sufit R. et al. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthr. and Rheum. 2011; 63 (11): 3633–3639.
Рецензия
Для цитирования:
Анаев Э.Х., Чучалин А.Г. Легочные эозинофилии: диагностика, подходы к терапии. Пульмонология. 2012;(4):106-115. https://doi.org/10.18093/0869-0189-2012-0-4-106-115
For citation:
Anaev E.Kh., Chuchalin A.G. Pulmonary eosinophilias, diagnosis and therapy approach. PULMONOLOGIYA. 2012;(4):106-115. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-4-106-115
Просмотров:
1198
Послать статью по эл. почте 